What is Friedreich Ataxia

Friedreich Ataxia is a rare, inherited, progressive neurodegenerative disorder that primarily affects the nervous system and the heart. It is caused by a genetic mutation that limits the production of frataxin, a protein essential for the proper function of mitochondria, the energy-producing centers of our cells.

What exactly is Friedreich Ataxia?

Friedreich Ataxia (FA) is a multisystem condition that progressively damages the spinal cord, peripheral nerves, and the cerebellum, the part of the brain responsible for coordination. Because it affects the mitochondria, the disease impacts high-energy tissues, most notably the heart and the nervous system. While the progression of Friedreich Ataxia varies significantly between individuals, it is fundamentally characterized by the loss of muscle control, known as ataxia, which typically worsens over time.

How does Friedreich Ataxia affect the body?

The clinical presentation of Friedreich Ataxia is diverse, but it generally impacts several key areas of health:

• Neurological: Progressive loss of coordination (ataxia) in the arms and legs, muscle weakness, and impaired speech (dysarthria).


• Cardiac: Many individuals with Friedreich Ataxia develop hypertrophic cardiomyopathy, a thickening of the heart muscle that requires regular monitoring by a cardiologist.


• Skeletal: Scoliosis (curvature of the spine) and foot deformities, such as high arches, are common.


• Metabolic: There is an increased risk of developing diabetes or glucose intolerance as the disease progresses.

Is Friedreich Ataxia hereditary?

Yes, Friedreich Ataxia is an autosomal recessive genetic condition. This means that a person must inherit two copies of the mutated FXN gene—one from each parent—to develop the disease. Parents who are carriers of the mutation typically do not show symptoms. In the DiseaseMaps.org community, 105 people with Friedreich Ataxia have joined to share their experiences, highlighting the importance of genetic counseling for families affected by this condition.

Who is typically affected by Friedreich Ataxia?

The prevalence of Friedreich Ataxia is estimated to be approximately 1 in 40,000 to 50,000 individuals in the general population of European descent. Symptoms most commonly begin during childhood or adolescence, typically between the ages of 5 and 15, though "late-onset" cases can occur in adulthood. There is no significant difference in distribution between genders, and the condition is found globally, though it is most frequently diagnosed in populations of European, Middle Eastern, and North African descent.

What differentiates Friedreich Ataxia from other conditions?

While many conditions cause ataxia, Friedreich Ataxia is unique due to its specific genetic cause (an expanded GAA triplet repeat in the FXN gene) and its multisystem involvement. Unlike some other forms of hereditary ataxia that affect only the brain, Friedreich Ataxia is distinguished by the combination of neurological symptoms with significant cardiac involvement and diabetes, which makes a multidisciplinary care approach essential.

Next steps

• Consult a neurologist specializing in movement disorders or ataxia for a comprehensive clinical assessment.


• Schedule an evaluation with a cardiologist to screen for cardiomyopathy, which is a standard part of care for Friedreich Ataxia.


• Connect with the 105 community members at DiseaseMaps.org to find peer support and shared experiences.


• Speak with a clinical geneticist to understand family risk and discuss potential clinical trial participation.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Friedreich Ataxia.


• Orphanet: Friedreich Ataxia (ORPHA:87).


• OMIM (Online Mendelian Inheritance in Man): Entry #229300 (Friedreich Ataxia).


• Friedreich's Ataxia Research Alliance (FARA): Patient resources and research updates.